Splenic vein thrombosis risk factors: Difference between revisions
Jump to navigation
Jump to search
Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{Vbe}} | {{CMG}} ; {{AE}} {{Vbe}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of splenic vein thrombosis include: Abdominal cancer, liver cirrhosis, surgery, thrombophilias, hormonal treatments, myeloproliferative disorders, sickle cell anemia | Common [[risk factors]] in the development of [[splenic vein thrombosis]] include: [[Abdominal cancer]], [[liver cirrhosis]], [[surgery]], thrombophilias, hormonal treatments, [[Myeloproliferative disease|myeloproliferative disorders]], [[sickle cell anemia]] | ||
== Risk factors== | == Risk factors== | ||
Common risk factors in the development of splenic vein thrombosis include: | Common [[risk factors]] in the development of [[splenic vein thrombosis]] include: | ||
*Abdominal cancer | *[[Abdominal cancer]] | ||
* Liver cirrhosis | * [[Liver cirrhosis]] | ||
* Surgery | * [[Surgery]] | ||
*Thrombophilias <ref name="pmid23026649">{{cite journal |vauthors=Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W |title=Clinical approach to splanchnic vein thrombosis: risk factors and treatment |journal=Thromb. Res. |volume=130 Suppl 1 |issue= |pages=S1–3 |year=2012 |pmid=23026649 |doi=10.1016/j.thromres.2012.08.259 |url=}}</ref> | *Thrombophilias <ref name="pmid23026649">{{cite journal |vauthors=Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W |title=Clinical approach to splanchnic vein thrombosis: risk factors and treatment |journal=Thromb. Res. |volume=130 Suppl 1 |issue= |pages=S1–3 |year=2012 |pmid=23026649 |doi=10.1016/j.thromres.2012.08.259 |url=}}</ref> | ||
*Hormonal | *[[Hormonal]] treatments | ||
* Myeloproliferative disorders | * [[Myeloproliferative disease|Myeloproliferative disorders]] | ||
*Sickle cell anemia <ref name="pmid26958556">{{cite journal |vauthors=Malamood M, Bernstein G, Malik Z, Mathur M |title=Massive Esophageal Variceal Bleeding as a Rare Complication of Sickle Cell Anemia |journal=ACG Case Rep J |volume=3 |issue=2 |pages=92–4 |year=2016 |pmid=26958556 |pmc=4748192 |doi=10.14309/crj.2016.10 |url=}}</ref> | *[[Sickle cell anemia]] <ref name="pmid26958556">{{cite journal |vauthors=Malamood M, Bernstein G, Malik Z, Mathur M |title=Massive Esophageal Variceal Bleeding as a Rare Complication of Sickle Cell Anemia |journal=ACG Case Rep J |volume=3 |issue=2 |pages=92–4 |year=2016 |pmid=26958556 |pmc=4748192 |doi=10.14309/crj.2016.10 |url=}}</ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 15:17, 16 January 2018
Splenic vein thrombosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Splenic vein thrombosis risk factors On the Web |
American Roentgen Ray Society Images of Splenic vein thrombosis risk factors |
Risk calculators and risk factors for Splenic vein thrombosis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
Common risk factors in the development of splenic vein thrombosis include: Abdominal cancer, liver cirrhosis, surgery, thrombophilias, hormonal treatments, myeloproliferative disorders, sickle cell anemia
Risk factors
Common risk factors in the development of splenic vein thrombosis include:
- Abdominal cancer
- Liver cirrhosis
- Surgery
- Thrombophilias [1]
- Hormonal treatments
- Myeloproliferative disorders
- Sickle cell anemia [2]
References
- ↑ Riva N, Donadini MP, Dentali F, Squizzato A, Ageno W (2012). "Clinical approach to splanchnic vein thrombosis: risk factors and treatment". Thromb. Res. 130 Suppl 1: S1–3. doi:10.1016/j.thromres.2012.08.259. PMID 23026649.
- ↑ Malamood M, Bernstein G, Malik Z, Mathur M (2016). "Massive Esophageal Variceal Bleeding as a Rare Complication of Sickle Cell Anemia". ACG Case Rep J. 3 (2): 92–4. doi:10.14309/crj.2016.10. PMC 4748192. PMID 26958556.